WN
ANGO icon

Williams & Novak’s AngioDynamics ANGO Stock Holding History

Williams & Novak’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,155
Closed -$156K – 147
2025
Q4 		$156K Sell
12,155
-300
-2% -$3.7K 0.12% 110
2025
Q3 		$139K Hold
12,455
– – 0.11% 117
2025
Q2 		$124K Sell
12,455
-4,755
-28% -$46.5K 0.11% 110
2025
Q1 		$166K Sell
17,210
-3,195
-16% -$33.6K 0.16% 96
2024
Q4 		$187K Buy
20,405
+320
+2% +$2.35K 0.18% 108
2024
Q3 		$156K Sell
20,085
-24,280
-55% -$175K 0.15% 109
2024
Q2 		$268K Buy
44,365
+21,550
+94% +$133K 0.25% 91
2024
Q1 		$179K Hold
22,815
– – 0.2% 83
2023
Q4 		$179K Buy
+22,815
New +$158K 0.2% 83

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Williams & Novak's ANGO Position: Q1 2026 in Review

Williams & Novak sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 12,155 shares — an estimated $156K sold.

Williams & Novak first reported a position in ANGO in Q4 2023 and held it in 9 quarters. The position peaked at $268K in Q2 2024. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Williams & Novak reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • Williams & Novak sold 12,155 AngioDynamics shares in Q1 2026, an estimated $156K.
  • Williams & Novak first reported a position in AngioDynamics in Q4 2023 and held it in 9 quarters.
  • Williams & Novak's AngioDynamics position peaked at $268K in Q2 2024.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Williams & Novak's 13F filing for Q1 2026, filed 21 Apr 2026.